- Home
- MFIN vs STXS Comparison
MFIN vs STXS Comparison
Compare MFIN & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIN
- STXS
- Stock Information
- Founded
- MFIN 1995
- STXS 1990
- Country
- MFIN United States
- STXS United States
- Employees
- MFIN N/A
- STXS N/A
- Industry
- MFIN Finance: Consumer Services
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MFIN Finance
- STXS Health Care
- Exchange
- MFIN Nasdaq
- STXS Nasdaq
- Market Cap
- MFIN 243.9M
- STXS 254.1M
- IPO Year
- MFIN 1996
- STXS 2004
- Fundamental
- Price
- MFIN $10.75
- STXS $2.82
- Analyst Decision
- MFIN Strong Buy
- STXS
- Analyst Count
- MFIN 1
- STXS 0
- Target Price
- MFIN $12.00
- STXS N/A
- AVG Volume (30 Days)
- MFIN 36.8K
- STXS 349.3K
- Earning Date
- MFIN 10-28-2025
- STXS 11-10-2025
- Dividend Yield
- MFIN 4.65%
- STXS N/A
- EPS Growth
- MFIN N/A
- STXS N/A
- EPS
- MFIN 1.75
- STXS N/A
- Revenue
- MFIN $332,256,000.00
- STXS $31,806,000.00
- Revenue This Year
- MFIN N/A
- STXS $30.92
- Revenue Next Year
- MFIN $1.53
- STXS $43.27
- P/E Ratio
- MFIN $5.90
- STXS N/A
- Revenue Growth
- MFIN 16.48
- STXS 33.94
- 52 Week Low
- MFIN $7.61
- STXS $1.54
- 52 Week High
- MFIN $10.98
- STXS $3.05
- Technical
- Relative Strength Index (RSI)
- MFIN 57.68
- STXS 54.60
- Support Level
- MFIN $10.33
- STXS $2.73
- Resistance Level
- MFIN $10.87
- STXS $2.94
- Average True Range (ATR)
- MFIN 0.25
- STXS 0.09
- MACD
- MFIN -0.03
- STXS -0.02
- Stochastic Oscillator
- MFIN 78.69
- STXS 55.56
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.